MTOR and breast carcinoma: The phosphatidylinositol‐3‐kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) and the mitogen‐activated protein kinase (MAPK) pathways play important roles in breast cancer pathophysiology 1.